Name
EstPharma OÜ
Registry code
14915921
VAT number
EE102242135
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
19.02.2020 (6)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
4 733 689 €
80 676 €
2%
-
-207 476 €
17
Submitted
No tax arrears
-39%
8%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Omanikukonto: Merilin Nurk-Bonde
| 100% - 2 500.00 EUR | Board member | Direct ownership |
| 2020 30.06.2021 | 2021 30.06.2022 | 2022 30.06.2023 | 2023 30.06.2024 | 2024 30.06.2025 | |
|---|---|---|---|---|---|
| Total Revenue | 2 668 745 € | 3 020 027 € | 3 378 784 € | 4 359 356 € | 4 733 689 € |
| Net profit (loss) for the period | -132 625 € | 83 937 € | -98 527 € | -143 437 € | 80 676 € |
| Profit Margin | -5% | 3% | -3% | -3% | 2% |
| Current Assets | 661 121 € | 474 132 € | 677 372 € | 739 828 € | 1 026 550 € |
| Fixed Assets | - | 1 772 € | 1 227 € | 682 € | 136 € |
| Total Assets | 661 121 € | 475 904 € | 678 599 € | 740 510 € | 1 026 686 € |
| Current Liabilities | 791 246 € | 522 092 € | 823 314 € | 1 028 662 € | 1 234 162 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | -130 125 € | -46 188 € | -144 715 € | -288 152 € | -207 476 € |
| Employees | 17 | 14 | 17 | 17 | 17 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 1 463 748 € | 81 747 € | 68 317 € | 26 |
| 2025 Q3 | 1 413 538 € | 85 211 € | 74 029 € | 26 |
| 2025 Q2 | 1 269 727 € | 69 173 € | 67 734 € | 25 |
| 2025 Q1 | 1 606 841 € | 136 029 € | 76 523 € | 26 |
| 2024 Q4 | 1 307 842 € | 80 307 € | 70 299 € | 25 |
| 2024 Q3 | 1 089 706 € | 82 547 € | 74 177 € | 25 |
| 2024 Q2 | 1 194 747 € | 73 727 € | 67 303 € | 26 |
| 2024 Q1 | 1 293 960 € | 78 291 € | 67 715 € | 25 |
| 2023 Q4 | 1 193 163 € | 77 783 € | 68 966 € | 24 |
| 2023 Q3 | 1 107 076 € | 77 608 € | 71 459 € | 24 |
| 2023 Q2 | 1 184 115 € | 69 618 € | 63 290 € | 24 |
| 2023 Q1 | 1 151 555 € | 68 433 € | 63 009 € | 25 |
| 2022 Q4 | 1 069 044 € | 69 725 € | 63 542 € | 25 |
| 2022 Q3 | 790 954 € | 52 182 € | 49 478 € | 25 |
| 2022 Q2 | 799 019 € | 50 954 € | 40 859 € | 22 |
| 2022 Q1 | 820 536 € | 52 883 € | 43 461 € | 21 |
